While Congress is busy figuring out how to keep track of the ballooning overseas drug manufacturing business, the industry is busy moving up the off-shore food chain, from basic manufacturing to the more complex task of researching new drugs.
Genzyme, a Cambridge-based biotech shop, said yesterday that it’s spending $90 million to build a 350-person R&D [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment